Showing results (21-30 of 99) with videos related to
Sort By:
Pageof 10
Cardiovascular Research|October 3, 2003
HIV infection, highly active antiretroviral therapy and the cardiovascular systemGiuseppe BarbaroJournal of Cardiovascular Risk|October 24, 2002
HIV infection, antiretroviral therapy and cardiovascular riskGiuseppe BarbaroBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 15, 2003
Good safety profile and efficacy of leucocyte interferon-alpha in combination with oral ribavirin in treatment-naive patients with chronic hepatitis C: a multicentre, randomised, controlled studyGiuseppe Barbaro, Benvenuto Grisorio, Luigi Fruttaldo, et al.Current Diabetes Reports|February 5, 2009
Metabolic syndrome associated with HIV and highly active antiretroviral therapyGiuseppe Barbaro, Gialuca IacobellisAIDS (London, England)|July 23, 2003
Incidence of the involvement of the cardiovascular system in HIV infectionGiorgio Barbarinia, Giuseppe BarbaroNutrition (Burbank, Los Angeles County, Calif.)|November 12, 2018
Epicardial adipose tissue feeding and overfeeding the heartGianluca Iacobellis, Giuseppe BarbaroBMC Gastroenterology|February 23, 2010
Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trialFabrizio Mecenate, Adriano M Pellicelli, Giuseppe Barbaro, et al.AIDS Reviews|August 3, 2002
HIV infection and the cardiovascular systemGiuseppe Barbaro, Edward C KlattCurrent Pharmaceutical Design|May 29, 2003
Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patientsGiuseppe Barbaro, Edward C KlattJournal of Medical Virology|December 2, 2009
Early emergence of raltegravir resistance mutations in patients receiving HAART salvage regimensFausto Baldanti, Stefania Paolucci, Roberto Gulminetti, et al.Pageof 10